Feature | February 22, 2013

Global Breast Biopsy Device Market Will Grow Steadily

Minimally Invasive Breast Biopsy Millenium Research Group

February 22, 2013 — According to Millennium Research Group (MRG), the growing demographic at risk for breast cancer and increasing compliance with screening programs will spur demand for breast biopsies. Additionally, patients and clinicians are showing a growing preference for minimally invasive biopsies over open surgical alternatives. As a result, sales of breast biopsy devices used in these procedures will expand at a steady pace through 2017.

Within minimally invasive breast biopsies, clinicians are moving toward using more accurate methods, such as core needle biopsy (CNB) and vacuum-assisted biopsy (VAB), and away from fine-needle aspiration (FNA). VAB in particular is driving growth in this market because this is the most diagnostically accurate method of breast biopsy and VAB devices have higher selling prices. VAB devices will therefore continue to represent the largest and fastest-growing segment of the breast biopsy device market over the next five years, generating significant interest from competitors.

"The competitive landscape of the VAB device market has changed considerably since 2010," said MRG Analyst Michelle Chan. "That year, Devicor Medical Products purchased Ethicon Endo-Surgery's breast care business and therefore acquired the Mammotome brand, which is arguably the most well-recognized brand in VAB. C. R. Bard also purchased SenoRx, giving it access to the EnCor VAB device."

The shift toward VAB has not occurred at the same rate worldwide. In the United States, more than 50 percent of minimally invasive breast biopsies are performed using this technique, which has supported the large size of the U.S. market. In China, however, less than one-quarter of procedures use VAB. Nonetheless, the shift toward VAB will be the fastest in China through 2017 due to its expanding economy and the ongoing shift away from open surgical biopsies. Japan is the only country where there is still a strong preference for less expensive FNA, causing it to be the smallest regional market.

MRG’s Global Markets for Breast Biopsy Devices 2013 report includes unit, average selling price and revenue information, along with market drivers and limiters and a competitive landscape for VAB devices, CNB devices and fine needles in the United States, Europe (France, Germany, Italy and the United Kingdom), Japan and China.

For more information: www.MRG.net, www.DecisionResourcesGroup.com

Related Content

Transpara Deep Learning Software Matches Experienced Radiologists in Mammogram Reading
News | Computer-Aided Detection Software | January 12, 2018
Deep learning and artificial intelligence improves the efficiency and accuracy of reading mammograms, according to...
Fat Distribution in Women and Men Provides Clues to Heart Attack Risk
News | Women's Health | January 11, 2018
January 11, 2018 – It’s not the amount of fat in your body but where it is stored that may increase your risk for hea
Women Prefer Getting Mammograms Every Year
News | Mammography | January 09, 2018
Women prefer to get their mammograms every year, instead of every two years, according to a new study presented at the...
Planmed Clarity 2-D Digital Mammography System Receives FDA Approval
Technology | Mammography | January 08, 2018
The U.S. Food and Drug Administration (FDA) issued an approval letter for the Planmed Clarity 2-D full-field digital...
Overweight Women May Need More Frequent Mammograms
News | Mammography | January 04, 2018
Women with higher body mass index (BMI) face an increased risk of not detecting their breast tumor until it has become...
About 25 percent of screening patients and 60 percent of diagnostic patients do not have prior mammograms available for comparison at the time of their examinations due to the lack of interoperability or other restrictions preventing clinicians from accessing prior exams.

About 25 percent of screening patients and 60 percent of diagnostic patients do not have prior mammograms available for comparison at the time of their examinations due to the lack of interoperability or other restrictions preventing clinicians from accessing prior exams.

Feature | Breast Imaging | January 02, 2018 | Kathryn Pearson Peyton, M.D.
Sixty million women undergo regular screening mammography in the United States, but even in the digital age, it is di
Imagio Opto-Acoustic Breast Imaging System Helps Differentiate Tumor Subtypes
News | Oncology Diagnostics | January 02, 2018
Seno Medical Instruments Inc. (Seno Medical) recently reported data from their clinical study demonstrating that its...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Double Black Announces Gemini Series Monitors for Multimodality and Digital Breast Imaging
Technology | Flat Panel Displays | December 28, 2017
December 28, 2017 — Double Black Imaging and their Image Systems Division are releasing their Gemini Series 6MP and 8
Overlay Init